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Summary.-Thymectomy effectively prevents the development of spontaneous
lymphoma in the AKR but how this effect is achieved remains to be determined.
One possible mechanism, namely suppression of genomic expression of the onco-
genic murine leukaemia virus now seems unlikely since levels of the group specific
MuLV antigen were in comparison with their sham operated controls unaltered in
both neonatally and adult thymectomized AKR.
ALTHOUGH quite clearly involved, the
exact role of the thymus in the develop-
ment of the lymphoma which charac-
terizes the AKR (Furth, Seiboldand Rath-
bone, 1933) still remains to be deter-
mined (Miller, 1961). One possible effect of
thymectomy may be to suppress the
titres of murine leukaemia virus group
specific antigens and this has been exam-
ined here in both neonatally and adult
thymectomized AKR.
MATERIALS AND METHODS
Mice.-The derivation of the AKR/CRC
used here has been described previously
(Barnes andTuffrey, 1974). Initially AKR/J
they were then maintained at the Laboratory
Animal Centre, Carshalton before being
transferred first to the National Institute of
Medical Research at Mill Hill and then to the
Clinical Research Centre. At all times the
colony was maintained by brother-sister
mating. As noted earlier, the AKR/CRC
subline have a high incidence oflymphomata
reaching 100% by 56 weeks of age (Barnes,
Tuffrey and Ford, 1973).
Surgery.-The mice were either thymecto-
mized or sham operated. In both cases the
procedure either took place during the first
24 h of life or at varying intervals from the
age of 4 weeks. Details of the technique of
thymectomy have been described previously
(Tuffrey, Kingman and Barnes, 1973). In
the case of the mice operated on during the
first 24 h of life, hypothermia was employed.
Anaesthesia in adult groups aged between
6 and 9 weeks was achieved using bromethol
(Avertin), 0 01 ml/g body weight i.p. of2.5%
solution).
Investigation.-Animalswerekilled atvari-
ousintervalsfollowingthymectomy. Successof
thymectomy was confirmed by histological
examination of serial sections prepared from
the mediastinum.
Tissues and serum were obtained at
sacrifice and stored at-20°C until investi-
gated. The indirect immunofluorescent
absorption technique of Hilgers (Hilgers
et al., 1974) was performed to determine
the gs-antigen titres, but here against fixed
AKR-A lymphoma cells. The AKR-A
lymphoma cell line was originally derived by
Woods et al. (1970) and maintained here at
the Clinical Research Centre by Dr Jennifer
Harvey. In essence, the gs-antigen test
is in 2 stages: first the titration of the
specific anti-MuLV-gs sera against the target
AKR-Alymphoma cells, followed by a second
titration after absorption with soluble anti-
gens obtained in the case of solid tissues
after ultrasonic disintegration. The gs-
antigen titre is expressed as the reciprocal
of the reduction in antibody titre following
absorption (I.F.A.). In all cases coded
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samples were examined and the results were
then subsequently related to each animal and
to the success of surgery. Some untreated
controls were also included. These were 3
old AKR with lymphomata and some young
CBA/H-T6.
RESULTS
The results of the gs-antigen titres in
the adult thymectomized and sham
operated AKR are shown in Table I.
Thymectomized mice in which a micro-
scopic remnant of lymphoid tissue (prob-
ably lymph node) was subsequently found
on histological examination were main-
tained as a separate subgroup.
The results of the gs-antigen titres
from the neonatally thymectomized and
sham thymectomized AKR are shown in
Table II. The distribution of MuLV-gs
antigen appears in good agreement with
the titres described by Hilgers et al. (1974).
Although we were unable to detect any
MuLV-gs antigen in any of our serum
samples, we were able to detect MuLV-gs
antigen in the spleen, liver and kidney
from one week of age. Highest titres
wereusuallydetected inthespleensamples,
apart from those recorded from control
AKR mice with thymoma (Table III).
This is also in accord with the infectivity
titres recorded by Rowe and Piiicus (1972).
It should be noted that the titres in the
AKR are somewhat lower than those
described by previous workers (Hilgers
et al., 1974). This difference is due solely
to technical variation in determination of
the " end point ".
It is quite obvious from these results
that thymrectomy, whether neonatal or
between 4 and 9 weeks of age, has no
effect upon MuLV-gs titres.
DISCUSSION
The involvement of the oncogenic
virus in the disease of the AKR strain
was clearly established by Gross (1951,
1957). Although the role of the thymus
in the disease process of the AKR remains
speculative, thymectomy at any stage
before the development of a lymphoma
effectively prevents the disease (McEndy,
Boon and Furth, 1944; Law and Miller,
1950). This advantage might act in one
ofseveralways, onebeingthatthymectomy
might suppress viral gene expression and
its neoplastic sequelae. From the findings
here, this view seems unlikely since com-
parable amounts of MuLV-gs antigen
were found in both sham operated and
thymectomized AKR. These results can
be considered to support Miller's (1960)
work in which he showed that his " leukae-
mic agent" was able to multiply when
transferred through a series of thymecto-
mized hosts. Nakakuki, Shisa and Nishi-
zuka (1967) suggested that the viral con-
centration needed to reach a critical level
to enable initiation of neoplastic trans-
formation, however it would appear that
the protective effect of thymectomy is
not in reducing the MuLV-gs titre and
therefore possibly the level of infectious
virus.
The most obvious interpretation would
TABLE III.-MIuLV-qs Titres on Tissues and Serum of Leuk-aemic AKR/CRC and
normal. CBA/H-T6 Mice
Controls (age days) No. of animals Spleen Kidney Liver Thymus Serum B/M L/N
AKR* 1 8 2 16 16 4 8 16
2 4 1 8 16 8 8 4
3 8 2 16 16 8 4 nt
CBA 1 (6) days
2 (9) days
3 (+ 100)
7
4
3
0
0
0
0
'0
0
0
0
0
0
0
0)
0
0
0
nt
nt
nt
nt
nt
nt
Results expresse(l as reciprocal of I.F.A. titres.
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be that the target cells for neoplastic
conversion are removed. However,
Miller (1961) clearly demonstrated that
by grafting CBA/H-T6 andAKRthymuses
into thymectomized (AKR x T6) Fl, the
resulting leukaemlic cells were of host
origin which suggested that the "thvmic
influence responsible for leukaeinic change
was a non-cellular indirect one".
It is now established that AKR mice
are not permanently tolerant to MuLV
since anti-MuLV gs antibodies are formed
and can be demonstrated as antibody-
antigen complexes in the kidneys from
about 3 months of age (Oldstone
et al., 1972). Since MuLV-gs antigen
levels are unchanged in non-leukaemic
thymectomized AKR mice, we are at
present looking for antibodies in these
animals to see whether tolerance to the
virus has been maintained and whether
this is in fact related to tumour develop-
ment a view that has been suggested
earlier (Barnes and Tuffrey, 1974).
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